117 related articles for article (PubMed ID: 23329453)
1. Breast cancer diagnostics using microfluidic multiplexed immunohistochemistry.
Kim MS; Kwon S; Park JK
Methods Mol Biol; 2013; 949():349-64. PubMed ID: 23329453
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer diagnosis using a microfluidic multiplexed immunohistochemistry platform.
Kim MS; Kim T; Kong SY; Kwon S; Bae CY; Choi J; Kim CH; Lee ES; Park JK
PLoS One; 2010 May; 5(5):e10441. PubMed ID: 20454672
[TBL] [Abstract][Full Text] [Related]
3. Quantitative proteomic profiling of breast cancers using a multiplexed microfluidic platform for immunohistochemistry and immunocytochemistry.
Kim MS; Kwon S; Kim T; Lee ES; Park JK
Biomaterials; 2011 Feb; 32(5):1396-403. PubMed ID: 21093044
[TBL] [Abstract][Full Text] [Related]
4. Micro-fluidic chip platform for the characterization of breast cancer cells using aptamer-assisted immunohistochemistry.
Yeong Won J; Choi JW; Min J
Biosens Bioelectron; 2013 Feb; 40(1):161-6. PubMed ID: 22841444
[TBL] [Abstract][Full Text] [Related]
5. Pipetting-driven microfluidic immunohistochemistry to facilitate enhanced immunoreaction and effective use of antibodies.
Kim S; Kwon S; Cho CH; Park JK
Lab Chip; 2017 Feb; 17(4):702-709. PubMed ID: 28145545
[TBL] [Abstract][Full Text] [Related]
6. Multiplexed immunohistochemical detection of tumor markers in breast cancer tissue using laser ablation inductively coupled plasma mass spectrometry.
Giesen C; Mairinger T; Khoury L; Waentig L; Jakubowski N; Panne U
Anal Chem; 2011 Nov; 83(21):8177-83. PubMed ID: 21923169
[TBL] [Abstract][Full Text] [Related]
7. Biomarker barcodes: multiplexed microfluidic immunohistochemistry enables high-throughput analysis of tissue microarray.
Cho CH; Cho M; Park JK
Lab Chip; 2021 Sep; 21(18):3471-3482. PubMed ID: 34263282
[TBL] [Abstract][Full Text] [Related]
8. A novel, automated technology for multiplex biomarker imaging and application to breast cancer.
Clarke GM; Zubovits JT; Shaikh KA; Wang D; Dinn SR; Corwin AD; Santamaria-Pang A; Li Q; Nofech-Mozes S; Liu K; Pang Z; Filkins RJ; Yaffe MJ
Histopathology; 2014 Jan; 64(2):242-55. PubMed ID: 24330149
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous analysis of HER2 gene and protein on a single slide facilitates HER2 testing of breast and gastric carcinomas.
Hirschmann A; Lamb TA; Marchal G; Padilla M; Diebold J
Am J Clin Pathol; 2012 Dec; 138(6):837-44. PubMed ID: 23161718
[TBL] [Abstract][Full Text] [Related]
10. Micro-immunohistochemistry using a microfluidic probe.
Lovchik RD; Kaigala GV; Georgiadis M; Delamarche E
Lab Chip; 2012 Mar; 12(6):1040-3. PubMed ID: 22237742
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemistry in the era of personalised medicine.
McCourt CM; Boyle D; James J; Salto-Tellez M
J Clin Pathol; 2013 Jan; 66(1):58-61. PubMed ID: 23002284
[TBL] [Abstract][Full Text] [Related]
12. HER-2/neu analysis in breast cancer bone metastases.
Zustin J; Boddin K; Tsourlakis MC; Burandt E; Mirlacher M; Jaenicke F; Izbicki J; Ruether W; Rueger JM; Bokemeyer C; Simon R; Sauter G
J Clin Pathol; 2009 Jun; 62(6):542-6. PubMed ID: 19474354
[TBL] [Abstract][Full Text] [Related]
13. HER2 amplification status in breast cancer: a comparison between immunohistochemical staining and fluorescence in situ hybridisation using manual and automated quantitative image analysis scoring techniques.
Ellis CM; Dyson MJ; Stephenson TJ; Maltby EL
J Clin Pathol; 2005 Jul; 58(7):710-4. PubMed ID: 15976337
[TBL] [Abstract][Full Text] [Related]
14. Validation of a fully integrated microfluidic array device for influenza A subtype identification and sequencing.
Liu RH; Lodes MJ; Nguyen T; Siuda T; Slota M; Fuji HS; McShea A
Anal Chem; 2006 Jun; 78(12):4184-93. PubMed ID: 16771549
[TBL] [Abstract][Full Text] [Related]
15. Microfluidic on-chip immunohistochemistry directly from a paraffin-embedded section.
Cho CH; Kwon S; Kim S; Hong Y; Kim P; Lee ES; Park JK
Biomicrofluidics; 2018 Jul; 12(4):044110. PubMed ID: 30079122
[TBL] [Abstract][Full Text] [Related]
16. Microfluidic chips for protein differential expression profiling.
Armenta JM; Dawoud AA; Lazar IM
Electrophoresis; 2009 Apr; 30(7):1145-56. PubMed ID: 19288587
[TBL] [Abstract][Full Text] [Related]
17. Hidden HER-2/neu-positive breast cancer: how to maximize detection.
Carney WP
IDrugs; 2009 Apr; 12(4):238-42. PubMed ID: 19350468
[TBL] [Abstract][Full Text] [Related]
18. The expression analysis of periostin in human breast cancer.
Zhang Y; Zhang G; Li J; Tao Q; Tang W
J Surg Res; 2010 May; 160(1):102-6. PubMed ID: 19524268
[TBL] [Abstract][Full Text] [Related]
19. Comparison of immunohistochemistry by automated cellular imaging system (ACIS) versus fluorescence in-situ hybridization in the evaluation of HER-2/neu expression in primary breast carcinoma.
Tawfik OW; Kimler BF; Davis M; Donahue JK; Persons DL; Fan F; Hagemeister S; Thomas P; Connor C; Jewell W; Fabian CJ
Histopathology; 2006 Feb; 48(3):258-67. PubMed ID: 16430472
[TBL] [Abstract][Full Text] [Related]
20. Expression of HER2 and the coamplified genes GRB7 and MLN64 in human breast cancer: quantitative real-time reverse transcription-PCR as a diagnostic alternative to immunohistochemistry and fluorescence in situ hybridization.
Vinatzer U; Dampier B; Streubel B; Pacher M; Seewald MJ; Stratowa C; Kaserer K; Schreiber M
Clin Cancer Res; 2005 Dec; 11(23):8348-57. PubMed ID: 16322295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
